Product Information

PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1111 per EA under NDC 16714064702. Its NADAC has been published 173 times since May 3, 2023.

FDA first approved this application on Feb 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 45 MG TABLET

Pioglitazone
$0.1111per EA

Strength

45 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714064702

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202467

FDA Approved

2/6/2013

TE Code

AB

On Market Since

8/18/2022

Pharmacological Classes

PPAR alpha
PPAR gamma
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor Activity
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 173 times since May 3, 2023, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1111 per EA
All-time high$0.1465 (Jul 12, 2023)
All-time low$0.0964 (Nov 20, 2024)
52-week high$0.1277
52-week low$0.1111
Median price$0.1277
Average price$0.1259
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked173
Tracking sinceMay 3, 2023

Price History

1W

-1.4%

1M

-1.4%

3M

-7.1%

6M

-1.1%

1Y

-12.9%

3Y

-16.6%

5Y

N/A

All

-18.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1111 per EA (NDC 16714064702), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 18.7%. It has been tracked across 173 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?

Since May 3, 2023, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1465 (Jul 12, 2023), with a median of $0.1277 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 45 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 45 MG TABLET?

PIOGLITAZONE HCL 45 MG TABLET (NDC 16714064702) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.